The number of organ transplantations is increasing every year.
In 2011, more than 30,000 transplants took place in the European Union (EU) alone.1
Astellas is among the global leaders in transplantation, providing immunosuppressant treatments for solid organ transplants such as kidney, liver and heart. Astellas will continue playing a key role in the care of transplant patients. In future, we intend to expand our portfolio beyond immunosuppressant treatments and are currently investigating therapies for prevention of cytomegalovirus infections in transplant patients.
1. European Commission. Organ donation and transplantation. Facts and figures.
Learn more about our therapy areas:
Innovative therapies in preventing organ rejection after transplantation
World-leading approach in R&D to satisfy unmet patient needs in urological conditions
Our commitment is to developing first-in-class and best-in-class therapies
Addressing the complex challenges of serious fungal and bacterial infections
Pioneering treatments that effectively manage chronic pain